Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Aurora Cannabis stock

ACB.TO
CA05156X8843
A2P4EC

Price

7.28 CAD
Today +/-
-0.46 CAD
Today %
-8.92 %
P

Aurora Cannabis stock price

CAD
%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Aurora Cannabis stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Aurora Cannabis stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Aurora Cannabis stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Aurora Cannabis's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Aurora Cannabis Stock Price History

DateAurora Cannabis Price
10/1/20247.28 CAD
9/30/20247.96 CAD
9/27/20247.91 CAD
9/26/20247.77 CAD
9/25/20247.53 CAD
9/24/20247.72 CAD
9/23/20247.59 CAD
9/20/20247.77 CAD
9/19/20247.82 CAD
9/18/20247.96 CAD
9/17/20248.11 CAD
9/16/20248.00 CAD
9/13/20247.87 CAD
9/12/20247.65 CAD
9/11/20247.63 CAD
9/10/20247.67 CAD
9/9/20247.85 CAD
9/6/20247.33 CAD
9/5/20247.58 CAD
9/4/20247.66 CAD
9/3/20247.90 CAD

Aurora Cannabis Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Aurora Cannabis, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Aurora Cannabis from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Aurora Cannabis’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Aurora Cannabis. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Aurora Cannabis’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Aurora Cannabis’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Aurora Cannabis’s growth potential.

Aurora Cannabis Revenue, EBIT and net profit per share

DateAurora Cannabis RevenueAurora Cannabis EBITAurora Cannabis Net Income
2030e714 M CAD0 CAD95.56 M CAD
2029e596.79 M CAD95.78 M CAD82.63 M CAD
2028e479.23 M CAD80.39 M CAD68.23 M CAD
2027e400.26 M CAD17.94 M CAD2.76 M CAD
2026e335.79 M CAD-2.1 M CAD-18.22 M CAD
2025e308.23 M CAD-23.27 M CAD-29.95 M CAD
2024270.28 M CAD-175.72 M CAD-65.58 M CAD
2023173.69 M CAD-179.98 M CAD-197.84 M CAD
2022221.34 M CAD-345.43 M CAD-1.72 B CAD
2021245.25 M CAD-386.24 M CAD-693.63 M CAD
2020278.9 M CAD-541.1 M CAD-3.28 B CAD
2019245.5 M CAD-393.6 M CAD-293.5 M CAD
201855.2 M CAD-105.7 M CAD71.9 M CAD
201718.1 M CAD-17.1 M CAD-13 M CAD
20161.4 M CAD-7.6 M CAD-5.7 M CAD
20150 CAD-4.4 M CAD-9.5 M CAD
20140 CAD-800,000 CAD-1.8 M CAD
20130 CAD-400,000 CAD-400,000 CAD
20120 CAD-300,000 CAD-300,000 CAD
20110 CAD-300,000 CAD-300,000 CAD
20100 CAD0 CAD0 CAD
20090 CAD-100,000 CAD-100,000 CAD
2008100,000 CAD-200,000 CAD-200,000 CAD
20070 CAD0 CAD0 CAD

Aurora Cannabis Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M CAD)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M CAD)EBIT (M CAD)EBIT MARGIN (%)NET INCOME (M CAD)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e2028e2029e2030e
00000000011855245278245221173270308335400479596714
----------1,700.00205.56345.4513.47-11.87-9.80-21.7256.0714.078.7719.4019.7524.4319.80
----------44.4432.7320.00-32.37-53.06-43.89-17.34-1.11------
000000000081849-90-130-97-30-3000000
00000000-4-7-17-105-393-541-386-345-179-175-23-21780950
----------700.00-94.44-190.91-160.41-194.60-157.55-156.11-103.47-64.81-7.47-0.604.2516.7015.94-
0000000-1-9-5-1371-293-3,283-693-1,717-197-65-29-182688295
--------800.00-44.44160.00-646.15-512.681,020.48-78.89147.76-88.53-67.01-55.38-37.93-111.113,300.0020.5915.85
0.20.91.21.21.31.31.31.36.410.723.339.380.196.816.9121.4932.2743.22000000
------------------------
Details

Keystats

Revenue and Growth

The Aurora Cannabis Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Aurora Cannabis is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M CAD)RECEIVABLES (M CAD)OTHER REC. (M CAD)INVENTORIES (M CAD)OTHER CURRENT LIAB. (M CAD)CURRENT ASSETS (M CAD)TANGIBLE ASSETS (M CAD)LONG-T. INVEST. (M CAD)LONG-T. REC. (M CAD)INTANGIBLE ASSETS (M CAD)GOODWILL (B CAD)OTHER NON-CURRENT ASSETS (M CAD)NON-CURRENT ASSETS (B CAD)TOTAL ASSETS (B CAD)LIABILITIESCOMMON STOCK (B CAD)ADDITIONAL PAID-IN CAPITAL (k CAD)RETAINED EARNINGS (M CAD)OTHER EQUITY (M CAD)UNREAL. GAINS/LOSSES (M CAD)EQUITY (B CAD)LIABILITIES (M CAD)PROVISIONS (M CAD)OTHER SHORT-TERM LIAB. (M CAD)SHORT-TERM DEBTS (M CAD)LONG-TERM DEBT PORTION (M CAD)SHORT-TERM REC. (M CAD)LONG-T. LIAB. (M CAD)DEFERRED TAXES (M CAD)OTHER LIAB. (M CAD)LONG-T. LIABILITIES (M CAD)DEBT (B CAD)TOTAL CAPITAL (B CAD)
200720082009201020112012201320142015201620172018201920202021202220232024
                                   
0.41.61.61.61.41.10.60.90.30.2174.6136316169.2425.21439.14234.94117.48
00.1000000.20.60.11.38.683.945.242.0332.4735.0240.54
00000000.1004.36.528.48.914.4514.596.334.87
0000000002.37.743.2161.9157.3137.72139.93128.82186.38
0000000.100.12.65.625.470.440.146.48119.0174.8277.34
0.41.71.61.61.41.10.71.215.2193.5219.7660.6420.7665.89745.12479.93426.61
0000.10004.210.811.445.5246.4765.6946.4606.09233.47322.97294.32
00000000000334.4118.818.10.291.2100
000000001.71.80003.614.354.456.56.34
000000000031.1200.3688.4412.3367.4570.759.6840.85
00000000000.040.763.170.930.8900.020.04
000000000011.4124.993.354.162.9229.4238.5427.37
000000000.010.010.131.674.842.361.940.340.450.41
00000000.010.010.020.321.895.52.782.61.080.930.84
                                   
000000000.010.020.221.474.675.796.426.756.846.97
020030030000000000000000
0-0.2-0.3-0.4-0.5-0.8-1.2-1.6-7.6-11.2-12.2126.4-101.9-3,361-4,093.2-5,794.68-6,052.26-6,122.77
00000000009.7-44.5-188.3-273.6-293.39-298.1-298.33-288.87
000000000000000000
0000000000.010.221.554.382.152.040.660.490.56
00000001.91.31.78.847.538.719.713.2813.8621.9420.33
000000000000107.773.443.854.6248.8337.7
00000000.800.314.625.340.326.518.3643.7519.419.38
000000016.1600000000
00000000000.12.5249.7152.640.9433147.5657.22
00000003.77.4823.575.3436.4272.2116.38145.23237.74124.62
000000002.34.463.8200.8395.2378.6358.61236.4979.9747.57
00000000005.955.4913.902.8616.7516.19
000000000010.52.3189.41.992.0437.4370.1748.42
000000002.34.480.2258.5675.6384.4450.66276.77166.88112.18
000000000.010.010.10.331.110.660.570.420.40.24
00000000.010.010.020.321.885.492.812.61.080.90.8
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Aurora Cannabis provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Aurora Cannabis's financial health and stability.

Assets

Aurora Cannabis's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Aurora Cannabis must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Aurora Cannabis after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Aurora Cannabis's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M CAD)DEPRECIATION (M CAD)DEFERRED TAXES (M CAD)CHANGES IN WORKING CAPITAL (M CAD)NON-CASH ITEM (B CAD)PAID INTEREST (M CAD)PAID TAXES (M CAD)NET CASH FLOW FROM OPERATING ACTIVITIES (M CAD)CAPITAL EXPENDITURES (M CAD)CASH FLOW FROM INVESTING ACTIVITIES (M CAD)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M CAD)INTEREST INCOME AND EXPENSES (M CAD)NET DEBT CHANGE (M CAD)NET CHANGE IN EQUITY (M CAD)CASH FLOW FROM FINANCING ACTIVITIES (M CAD)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M CAD)TOTAL DIVIDENDS PAID (M CAD)NET CHANGE IN CASH FLOW (M CAD)FREE CASH FLOW (M CAD)SHARE-BASED COMPENSATION (M CAD)
20072008200920102011201220132014201520162017201820192020202120222023
0000000-1-9-5-1269-297-3,300-693-1,717-206
000000000011288114989332
0000000000-46-23-78-6-2-18
0000000000-2-25-377049-25
000000000.01-00.01-0.140.082.920.391.470.1
0000000000071847342716
00000000000000000
00000000-3-6-13-81-192-337-210-109-115
0000000-2-7-1-25-137-414-355-53-32-12
0000000-2-7-1-49-536-312-249-26-36-27
0000000000-23-39910210526-4-15
00000000000000000
0000000174104344583-37-122-170-129
01000002051202155957566635073
01000004108221535597582521147-71
0000000030-3-25-4544-21-31-14
00000000000000000
0100000000159-8395-1025916-202
0.02-0.09-0.04-0.06-0.28-0.28-0.45-3.39-11.15-8.65-39.1-219.2-606.55-692.96-263.66-142.05-127.95
00000000000000000

Aurora Cannabis stock margins

The Aurora Cannabis margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Aurora Cannabis. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Aurora Cannabis.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Aurora Cannabis's sales revenue. A higher gross margin percentage indicates that the Aurora Cannabis retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Aurora Cannabis's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Aurora Cannabis's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Aurora Cannabis's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Aurora Cannabis. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Aurora Cannabis's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Aurora Cannabis Margin History

Aurora Cannabis Gross marginAurora Cannabis Profit marginAurora Cannabis EBIT marginAurora Cannabis Profit margin
2030e-1.16 %0 %13.38 %
2029e-1.16 %16.05 %13.85 %
2028e-1.16 %16.78 %14.24 %
2027e-1.16 %4.48 %0.69 %
2026e-1.16 %-0.63 %-5.43 %
2025e-1.16 %-7.55 %-9.72 %
2024-1.16 %-65.01 %-24.26 %
2023-17.75 %-103.62 %-113.91 %
2022-44.03 %-156.06 %-776.02 %
2021-53.31 %-157.48 %-282.82 %
2020-32.34 %-194.01 %-1,177.38 %
201920.33 %-160.33 %-119.55 %
201832.61 %-191.49 %130.25 %
201747.51 %-94.48 %-71.82 %
2016-57.14 %-542.86 %-407.14 %
2015-1.16 %0 %0 %
2014-1.16 %0 %0 %
2013-1.16 %0 %0 %
2012-1.16 %0 %0 %
2011-1.16 %0 %0 %
2010-1.16 %0 %0 %
2009-1.16 %0 %0 %
2008-1.16 %-200 %-200 %
2007-1.16 %0 %0 %

Aurora Cannabis Stock Sales Revenue, EBIT, Earnings per Share

The Aurora Cannabis earnings per share therefore indicates how much revenue Aurora Cannabis has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Aurora Cannabis earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Aurora Cannabis's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Aurora Cannabis’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Aurora Cannabis's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Aurora Cannabis Revenue, EBIT and net profit per share

DateAurora Cannabis Sales per ShareAurora Cannabis EBIT per shareAurora Cannabis Earnings per Share
2030e13.06 CAD0 CAD1.75 CAD
2029e10.92 CAD0 CAD1.51 CAD
2028e8.77 CAD0 CAD1.25 CAD
2027e7.32 CAD0 CAD0.05 CAD
2026e6.14 CAD0 CAD-0.33 CAD
2025e5.64 CAD0 CAD-0.55 CAD
20246.25 CAD-4.07 CAD-1.52 CAD
20235.38 CAD-5.58 CAD-6.13 CAD
202210.3 CAD-16.07 CAD-79.92 CAD
202114.5 CAD-22.84 CAD-41.01 CAD
20202.88 CAD-5.59 CAD-33.92 CAD
20193.06 CAD-4.91 CAD-3.66 CAD
20181.4 CAD-2.69 CAD1.83 CAD
20170.78 CAD-0.73 CAD-0.56 CAD
20160.13 CAD-0.71 CAD-0.53 CAD
20150 CAD-0.69 CAD-1.48 CAD
20140 CAD-0.62 CAD-1.38 CAD
20130 CAD-0.31 CAD-0.31 CAD
20120 CAD-0.23 CAD-0.23 CAD
20110 CAD-0.23 CAD-0.23 CAD
20100 CAD0 CAD0 CAD
20090 CAD-0.08 CAD-0.08 CAD
20080.11 CAD-0.22 CAD-0.22 CAD
20070 CAD0 CAD0 CAD

Aurora Cannabis business model

Aurora Cannabis Inc is a Canadian company specializing in the cultivation, production, and sale of medical cannabis. The company was founded in 2006 and is headquartered in Edmonton, Alberta. Aurora Cannabis is considered one of the largest companies in the cannabis industry. Aurora Cannabis is one of the most popular companies on Eulerpool.com.

Aurora Cannabis SWOT Analysis

Strengths

Aurora Cannabis Inc, a leading Canadian cannabis company, possesses several strengths that contribute to its competitive position in the market. These strengths include:

  • A strong market presence and brand recognition.
  • Extensive production capacity and a diverse product portfolio.
  • Efficient cultivation methods and advanced technology.
  • Well-established distribution channels and strategic partnerships.
  • Solid financial performance and a strong balance sheet.

Weaknesses

Despite its strengths, Aurora Cannabis Inc also faces certain weaknesses, which may hinder its growth and performance:

  • Dependence on the Canadian market, limiting geographic diversification.
  • Significant regulatory constraints and compliance challenges within the cannabis industry.
  • High production costs and expenses affecting profitability.
  • Relatively low market share compared to some competitors.

Opportunities

Aurora Cannabis Inc has identified several opportunities that can be leveraged to drive further growth and success:

  • Expansion into international markets with evolving cannabis regulations.
  • Increasing acceptance and legalization of medical and recreational cannabis globally.
  • Investment in research and development for innovative cannabis products.
  • Mergers, acquisitions, and strategic partnerships to enhance market share and capabilities.

Threats

Aurora Cannabis Inc must also be aware of various threats that could impact its business and sustainability:

  • Intense competition from both domestic and international cannabis players.
  • Regulatory changes and uncertainties in the cannabis industry.
  • Volatility in cannabis prices and potential oversupply in the market.
  • Negative public perception and social stigma surrounding cannabis use.

Aurora Cannabis Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Aurora Cannabis historical P/E ratio, EBIT multiple, and P/S ratio

Aurora Cannabis shares outstanding

The number of shares was Aurora Cannabis in 2023 — This indicates how many shares 32.274 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Aurora Cannabis earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Aurora Cannabis's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Aurora Cannabis’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Aurora Cannabis's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Aurora Cannabis stock splits

In Aurora Cannabis's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Aurora Cannabis.

Eulerpool ESG Scorecard© for the Aurora Cannabis stock

Eulerpool World ESG Rating (EESG©)

20/ 100

🌱 Environment

4

👫 Social

42

🏛️ Governance

14

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Aurora Cannabis shareholders

%
Name
Stocks
Change
Date
2.03061 % Tidal Investments LLC1,109,947-724,2763/31/2024
1.88434 % Renaissance Technologies LLC1,029,998394,45612/31/2023
1.52680 % ETF Managers Group, LLC834,562834,5623/31/2023
0.48383 % Mirae Asset Global Investments (USA) LLC264,467-24,35312/31/2023
0.36090 % Two Sigma Investments, LP197,272131,12212/31/2023
0.32302 % Horizons ETFs Management (Canada) Inc.176,567-5,2132/29/2024
0.27475 % Susquehanna International Group, LLP150,178-12,59212/31/2023
0.27442 % Yong Rong (HK) Asset Management Limited150,000012/31/2023
0.20771 % AXS Investments LLC113,53880212/31/2023
0.18469 % Martin (Miguel)100,95363,6389/28/2023
1
2
3
4
5
...
10

Aurora Cannabis Executives and Management Board

Mr. Miguel Martin51
Aurora Cannabis Chief Executive Officer, Director (since 2020)
Compensation 6.72 M CAD
Mr. Glen Ibbott
Aurora Cannabis Chief Financial Officer
Compensation 2.13 M CAD
Mr. Alex Miller
Aurora Cannabis Executive Vice President - Operations and Supply Chain
Compensation 1.59 M CAD
Mr. Andre Jerome
Aurora Cannabis Executive Vice President - Global Business Development
Compensation 1.55 M CAD
Ms. Lori Schick
Aurora Cannabis Executive Vice President - Human Resources
Compensation 1.53 M CAD
1
2
3

Aurora Cannabis Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,86-0,09-0,220,49-0,01-
SupplierCustomer0,500,57-0,41-0,250,310,80
SupplierCustomer0,130,04-0,51-0,380,55-
1

Most common questions regarding Aurora Cannabis

What values and corporate philosophy does Aurora Cannabis represent?

Aurora Cannabis Inc represents values of innovation, sustainability, and transparency in the cannabis industry. With a strong corporate philosophy focused on product quality and customer satisfaction, Aurora aims to provide a wide range of high-quality cannabis products for both medical and recreational use. The company strives to stay ahead in research and development, ensuring cutting-edge solutions to meet the evolving needs of its consumers. Aurora's commitment to environmental conservation and sustainable practices sets it apart from its competitors, making it a trusted name in the cannabis market. By embodying these values and corporate philosophy, Aurora Cannabis Inc continues to be a leader in the industry.

In which countries and regions is Aurora Cannabis primarily present?

Aurora Cannabis Inc is primarily present in multiple countries and regions worldwide. With an expansive global footprint, the company operates in key markets such as Canada, where it is headquartered, and the United States. Additionally, Aurora Cannabis has a significant presence in Europe, including Germany, the United Kingdom, and the Netherlands. Furthermore, the company is actively expanding its reach in South America, primarily in countries like Uruguay and Colombia. By establishing a strong international presence, Aurora Cannabis Inc is well-positioned to capitalize on the global cannabis market and cater to diverse consumer needs in numerous countries and regions.

What significant milestones has the company Aurora Cannabis achieved?

Aurora Cannabis Inc has achieved several significant milestones in its operations. The company became the first licensed producer in Canada to successfully deliver cannabis products to Europe. Furthermore, Aurora Cannabis expanded its global footprint by acquiring multiple cannabis companies across different countries, strengthening its international presence. Additionally, the company has focused on research and innovation, developing advanced cultivation methods and breeding programs to enhance product quality and increase yields. Aurora Cannabis also listed on the New York Stock Exchange, providing it with broader access to capital markets and attracting a wider investor base. These milestones highlight Aurora Cannabis Inc's commitment to growth and leadership in the global cannabis industry.

What is the history and background of the company Aurora Cannabis?

Aurora Cannabis Inc is a Canadian-based company operating in the cannabis industry. Founded in 2006, Aurora has grown to become one of the largest and leading cannabis producers globally. The company is dedicated to producing high-quality medical cannabis products for both the domestic and international markets. It has established a strong presence in Canada and expanded its operations to various countries, including Europe and Australia. With a focus on innovation and research, Aurora Cannabis continues to invest in advanced cultivation techniques and is committed to promoting the therapeutic benefits of cannabis. The company's growth and success have positioned it as a key player in the rapidly evolving cannabis industry.

Who are the main competitors of Aurora Cannabis in the market?

The main competitors of Aurora Cannabis Inc in the market include Canopy Growth Corporation, Tilray Inc, and Cronos Group Inc. These companies are also prominent players in the cannabis industry, competing with Aurora Cannabis Inc in terms of market share, product offerings, and global expansion strategies.

In which industries is Aurora Cannabis primarily active?

Aurora Cannabis Inc is primarily active in the cannabis industry.

What is the business model of Aurora Cannabis?

The business model of Aurora Cannabis Inc, a leading Canadian cannabis company, revolves around the cultivation, production, and distribution of medical and recreational cannabis products. With a strong presence in Canada and expanding globally, Aurora aims to provide high-quality cannabis to meet the growing demand. The company's vertically integrated operations allow for control over the entire supply chain, from growing the plants to delivering the final products to consumers. Aurora focuses on innovative research and development to enhance its product portfolio and offers a wide range of cannabis products, including dried flowers, oils, capsules, and more.

What is the P/E ratio of Aurora Cannabis 2024?

The Aurora Cannabis P/E ratio is -4.8.

What is the P/S ratio of Aurora Cannabis 2024?

The Aurora Cannabis P/S ratio is 1.16.

What is the AlleAktien quality score of Aurora Cannabis?

The AlleAktien quality score for Aurora Cannabis is 4/10.

What is the revenue of Aurora Cannabis 2024?

The Aurora Cannabis revenue is 270.28 M CAD.

How high is the profit of Aurora Cannabis 2024?

The Aurora Cannabis profit is -65.58 M CAD.

What is the business model of Aurora Cannabis

Aurora Cannabis Inc. is a Canadian company specializing in the production and sale of medical and recreational cannabis, as well as other related products. It was founded in 2006 and is headquartered in Edmonton, Alberta. Currently, Aurora Cannabis Inc. is one of the world's largest and most diversified cannabis companies.

What is the Aurora Cannabis dividend?

Aurora Cannabis pays a dividend of 0 CAD distributed over payouts per year.

How often does Aurora Cannabis pay dividends?

The dividend cannot currently be calculated for Aurora Cannabis or the company does not pay out a dividend.

What is the Aurora Cannabis ISIN?

The ISIN of Aurora Cannabis is CA05156X8843.

What is the Aurora Cannabis WKN?

The WKN of Aurora Cannabis is A2P4EC.

What is the Aurora Cannabis ticker?

The ticker of Aurora Cannabis is ACB.TO.

How much dividend does Aurora Cannabis pay?

Over the past 12 months, Aurora Cannabis paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aurora Cannabis is expected to pay a dividend of 0 CAD.

What is the dividend yield of Aurora Cannabis?

The current dividend yield of Aurora Cannabis is .

When does Aurora Cannabis pay dividends?

Aurora Cannabis pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aurora Cannabis?

Aurora Cannabis paid dividends every year for the past 0 years.

What is the dividend of Aurora Cannabis?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aurora Cannabis located?

Aurora Cannabis is assigned to the 'Health' sector.

Wann musste ich die Aktien von Aurora Cannabis kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aurora Cannabis from 10/2/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Aurora Cannabis pay the last dividend?

The last dividend was paid out on 10/2/2024.

What was the dividend of Aurora Cannabis in the year 2023?

In the year 2023, Aurora Cannabis distributed 0 CAD as dividends.

In which currency does Aurora Cannabis pay out the dividend?

The dividends of Aurora Cannabis are distributed in CAD.

All fundamentals about Aurora Cannabis

Our stock analysis for Aurora Cannabis Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aurora Cannabis Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.